These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 8950136

  • 1. Effect of chronic treatment with atenolol and prazosin in streptozotocin induced diabetic rats.
    Goyal RK, Bangaru RA, Lakkad NB, Rao MV.
    Indian J Physiol Pharmacol; 1996 Jul; 40(3):220-4. PubMed ID: 8950136
    [Abstract] [Full Text] [Related]

  • 2. Comparative evaluation of atenolol and metoprolol on cardiovascular complications associated with streptozotocin-induced diabetic rats.
    Bhadada SV, Goyal RK.
    Can J Physiol Pharmacol; 2007 Aug; 85(8):831-6. PubMed ID: 17901894
    [Abstract] [Full Text] [Related]

  • 3. Release of beta-endorphin by prostaglandin E2 to lower plasma glucose in streptozotocin-induced diabetic rats.
    Cheng JT, Liu IM, Chi TC, Tzeng TF.
    Horm Metab Res; 2001 Jul; 33(7):439-43. PubMed ID: 11507683
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol.
    Phipps JA, Wilkinson-Berka JL, Fletcher EL.
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):927-34. PubMed ID: 17251496
    [Abstract] [Full Text] [Related]

  • 6. Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats.
    Ceylan-Isik A, Hünkar T, Aşan E, Kaymaz F, Ari N, Söylemezoğlu T, Renda N, Soncul H, Bali M, Karasu C, (Antioxidants in Diabetes-Induced Complications) The ADIC Study Group.
    J Pharm Pharmacol; 2007 Dec; 59(12):1629-41. PubMed ID: 18053324
    [Abstract] [Full Text] [Related]

  • 7. Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin diabetic and DOCA hypertensive rats.
    Sevak AR, Goyal RK.
    Pharmacol Res; 1996 Dec; 34(5-6):201-9. PubMed ID: 9076844
    [Abstract] [Full Text] [Related]

  • 8. Effect of oral magnesium sulfate administration on blood pressure and lipid profile in streptozocin diabetic rat.
    Soltani N, Keshavarz M, Dehpour AR.
    Eur J Pharmacol; 2007 Apr 10; 560(2-3):201-5. PubMed ID: 17292879
    [Abstract] [Full Text] [Related]

  • 9. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes.
    Koçak G, Aktan F, Canbolat O, Ozoğul C, Elbeğ S, Yildizoglu-Ari N, Karasu C, ADIC Study Group--Antioxidants in Diabetes-Induced Complications.
    Diabetes Nutr Metab; 2000 Dec 10; 13(6):308-18. PubMed ID: 11232755
    [Abstract] [Full Text] [Related]

  • 10. Effect of chronic treatment with losartan on streptozotocin induced diabetic rats.
    Murali B, Goyal RK.
    Indian J Exp Biol; 2002 Jan 10; 40(1):31-4. PubMed ID: 12561964
    [Abstract] [Full Text] [Related]

  • 11. [Parameters of systemic hemodynamics in conscious rats with acute streptozotocin diabetes].
    Kuznetsova LV, Medvedeva NA, Medvedev OS.
    Biull Eksp Biol Med; 1992 Mar 10; 113(3):250-2. PubMed ID: 1421217
    [Abstract] [Full Text] [Related]

  • 12. Beta-adrenoceptor-mediated vasodilation of retinal blood vessels is reduced in streptozotocin-induced diabetic rats.
    Nakazawa T, Sato A, Mori A, Saito M, Sakamoto K, Nakahara T, Ishii K.
    Vascul Pharmacol; 2008 Mar 10; 49(2-3):77-83. PubMed ID: 18585480
    [Abstract] [Full Text] [Related]

  • 13. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
    Wiśniewska RJ.
    Pol J Pharmacol; 1998 Mar 10; 50(3):213-23. PubMed ID: 9861629
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of methoxamine-induced contractile responses of rat ventricular muscle in streptozotocin-induced diabetes is associated with alpha1A adrenoceptor upregulation.
    Kamata K, Satoh T, Matsumoto T, Noguchi E, Taguchi K, Kobayashi T, Tanaka H, Shigenobu K.
    Acta Physiol (Oxf); 2006 Mar 10; 188(3-4):173-83. PubMed ID: 17054657
    [Abstract] [Full Text] [Related]

  • 15. Simvastatin treatment restores vasoconstriction and the inhibitory effect of LPC on endothelial relaxation via affecting oxidizing metabolism in diabetic rats.
    Ceylan A, Karasu C, Aktan F, Ozansoy G.
    Diabetes Nutr Metab; 2004 Aug 10; 17(4):203-10. PubMed ID: 15575340
    [Abstract] [Full Text] [Related]

  • 16. Diltiazem attenuates oxidative stress in diabetic rats.
    Anjaneyulu M, Chopra K.
    Ren Fail; 2005 Aug 10; 27(3):335-44. PubMed ID: 15957552
    [Abstract] [Full Text] [Related]

  • 17. Effect of hypertension on the development of diabetic cardiomyopathy.
    Mathis DR, Liu SS, Rodrigues BB, McNeill JH.
    Can J Physiol Pharmacol; 2000 Oct 10; 78(10):791-8. PubMed ID: 11077979
    [Abstract] [Full Text] [Related]

  • 18. Effects of cod liver oil on tissue antioxidant pathways in normal and streptozotocin-diabetic rats.
    Hünkar T, Aktan F, Ceylan A, Karasu C, Antioxidants in Diabetes-Induced Complications (ADIC) Study Group.
    Cell Biochem Funct; 2002 Dec 10; 20(4):297-302. PubMed ID: 12415563
    [Abstract] [Full Text] [Related]

  • 19. Chronic changes of the iris microvasculature of streptozotocin-induced diabetic rats using fluorescence videomicroscopy.
    Jariyapongskul A, Rungjaroen T, Kasetsuwan N, Pathumraj S, Niimi H.
    Clin Hemorheol Microcirc; 2006 Dec 10; 34(1-2):283-93. PubMed ID: 16543648
    [Abstract] [Full Text] [Related]

  • 20. The effects of voluntary exercise and prazosin on capillary rarefaction and metabolism in streptozotocin-induced diabetic male rats.
    Dunford EC, Leclair E, Aiken J, Mandel ER, Haas TL, Birot O, Riddell MC.
    J Appl Physiol (1985); 2017 Mar 01; 122(3):492-502. PubMed ID: 27932675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.